Position in HROW
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,574,958
+$2,926,655 QoQ
Shares Held
158,110
+192.5% QoQ
Ownership
0.424%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
12 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Derivatives in HROW
reported options exposure · as of Dec 31, 2025CallValue
$7,114,800
CallShares
145,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BOOTHBAY FUND MANAGEMENT, LLC holds $50,237,325 across 12 Drug Manufacturers - Specialty & Generic names. HROW ranks #3 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
625,048 | $23,589,311 | |
| 2 | ANIK |
Anika Therapeutics, Inc.
|
529,503 | $7,677,793 | |
| 3 | HROW |
Harrow, Inc.
This page
|
158,110 | $5,574,958 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
40,743 | $3,133,136 | |
| 5 | VTRS |
Viatris Inc
|
214,577 | $2,898,935 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
88,379 | $2,661,975 | |
| 7 | CRON |
Cronos Group Inc.
|
601,859 | $1,510,666 | |
| 8 | ETON |
Eton Pharmaceuticals, Inc.
|
55,605 | $1,372,331 |
All Filings in HROW
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,574,958 | 158,110 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $2,648,303 | 54,047 | Shares | Other | 2026-02-17 | |
| 2025-12-31 | $7,114,800 | 145,200 | Call | Other | 2026-02-17 | |
| 2025-09-30 | $5,396,160 | 112,000 | Call | Other | 2025-11-14 | |
| 2025-03-31 | $452,200 | 17,000 | Call | Other | 2025-05-15 | |
| 2024-12-31 | $570,350 | 17,000 | Call | Other | 2025-02-14 | |
| 2022-06-30 | $793,003 | 108,929 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $852,868 | 125,054 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $1,126,906 | 130,429 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $1,856,214 | 204,204 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $934,899 | 100,635 | Shares | Other | 2021-08-17 | |
| 2020-12-31 | $243,187 | 35,450 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $294,486 | 52,681 | Shares | Other | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||